Sample sizes in COVID-19–related research
Sample sizes in COVID-19–related research
Letter: Cheung and colleagues warned that underpowered studies that committed a type II error will discourage clinicians from using effective treatment.1 I agreed with this argument. Because the number of published clinical trials on coronavirus disease 2019 (COVID-19) patients has been increasing rapidly, I have reviewed all these trials published between Jan. 1, 2020, and Mar. 25, 2020, and indexed in PubMed, and assessed the quality of their sample size calculation.
Lee, Paul H.
02620eab-ae7f-4a1c-bad1-8a50e7e48951
27 April 2020
Lee, Paul H.
02620eab-ae7f-4a1c-bad1-8a50e7e48951
Lee, Paul H.
(2020)
Sample sizes in COVID-19–related research.
CMAJ, 192 (17), [E461].
(doi:10.1503/cmaj.75308).
Abstract
Letter: Cheung and colleagues warned that underpowered studies that committed a type II error will discourage clinicians from using effective treatment.1 I agreed with this argument. Because the number of published clinical trials on coronavirus disease 2019 (COVID-19) patients has been increasing rapidly, I have reviewed all these trials published between Jan. 1, 2020, and Mar. 25, 2020, and indexed in PubMed, and assessed the quality of their sample size calculation.
This record has no associated files available for download.
More information
Published date: 27 April 2020
Additional Information:
© 2020 Joule Inc. or its licensors
Identifiers
Local EPrints ID: 475050
URI: http://eprints.soton.ac.uk/id/eprint/475050
ISSN: 0820-3946
PURE UUID: 0ac5be34-62d1-45a3-9266-158d3516e58c
Catalogue record
Date deposited: 09 Mar 2023 18:49
Last modified: 06 Jun 2024 02:15
Export record
Altmetrics
Contributors
Author:
Paul H. Lee
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics